How Strategic Collaborations Transform Clinical Diagnostics

From Answers from the Lab by Mayo Clinic Laboratories

February 19, 2026 · 15 min · Episode 378

About this episode

The episode discusses how strategic collaborations are transforming clinical diagnostics with insights from industry leaders.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D. , president and CEO of Mayo Clinic Laboratories, to discuss recent industry news and how collaborations are helping drive transformation in clinical diagnostics. Together, they explore: Protecting Access to Medicare Act (PAMA) delay (01:09): Dr. Morice shares what the latest delay of PAMA means for laboratories. FDA guidance on wearables (02:23): Learn about recent FDA guidance that allows more non‑invasive wearables to be classified as wellness devices. Collaboration as a driver of innovation (06:20): Discover why collaboration is critical to advancement in clinical diagnostics. Note: Information in this post was accurate at the time of its posting. Resources Groundbreaking collaborations Mary Jo Williamson offers four steps to maximize collaboration benefits Dr. Bill Morice shares how a platform for collaboration transforms diagnostics “Answers From the Lab” podcast: “Forging Collaborations That Deliver Better Outcomes”

People in this episode

Host: Bobbi Pritt, M.D.

Guest: William Morice II, M.D., Ph.D.

Topics covered

clinical diagnostics
collaboration
FDA guidance
wearable devices
Medicare Act

Keywords

clinical diagnostics
collaboration
FDA guidance
wearables
PAMA delay

Mentioned in this episode

Organizations: Mayo Clinic Laboratories, FDA